PhaseBio Pharmaceuticals Inc
OTC:PHASQ
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Price:
0.0001
USD
Market Closed
Market Cap:
$49.9
Balance Sheet
Balance Sheet Decomposition
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Balance Sheet
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
74
|
28
|
42
|
|
| Cash Equivalents |
74
|
28
|
42
|
|
| Total Receivables |
1
|
0
|
0
|
|
| Other Current Assets |
4
|
12
|
7
|
|
| Total Current Assets |
79
|
40
|
49
|
|
| PP&E Net |
4
|
10
|
12
|
|
| PP&E Gross |
4
|
10
|
12
|
|
| Accumulated Depreciation |
2
|
2
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
82
N/A
|
50
-39%
|
61
+20%
|
|
| Liabilities | ||||
| Accounts Payable |
3
|
4
|
13
|
|
| Accrued Liabilities |
3
|
6
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
5
|
5
|
|
| Other Current Liabilities |
0
|
0
|
2
|
|
| Total Current Liabilities |
8
|
15
|
28
|
|
| Long-Term Debt |
12
|
7
|
1
|
|
| Other Liabilities |
2
|
54
|
124
|
|
| Total Liabilities |
23
N/A
|
76
+236%
|
154
+103%
|
|
| Equity | ||||
| Common Stock |
0
|
0
|
0
|
|
| Retained Earnings |
162
|
261
|
392
|
|
| Additional Paid In Capital |
222
|
236
|
299
|
|
| Treasury Stock |
0
|
0
|
0
|
|
| Total Equity |
60
N/A
|
25
N/A
|
93
-269%
|
|
| Total Liabilities & Equity |
82
N/A
|
50
-39%
|
61
+20%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
29
|
29
|
48
|
|
Switch to:
Switch to:
See Also
Discover More
